Analysts' recommendations: Avinger, Inc.

21/04/23	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/05/22	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
18/03/22	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/06/21	Avinger : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

More recommendations

Managers and Directors: Avinger, Inc.

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	05/08/2024

More insiders

Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq 00:00:00 15/02/2025 +03			5-day change	1st Jan Change
0.4740 ^USD	-20.74%		-.--%	-

20/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.42M 2.25M 2.05M 3.86M 261M 3.88M 27.19M 10.58M 133M 10.16M 9.94M 428M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.44M 10.66M 9.7M 18.27M 1.24B 18.41M 129M 50.12M 631M 48.15M 47.11M 2.03B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

20/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
11/02/25	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
11/02/25	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
11/02/25	Avinger, Inc. Announces Executive Changes	CI
24/12/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24/12/24	US Futures Tread Water Ahead of Holiday Break	MT
23/12/24	Iberdrola Completes Merger with Avangrid	MT
08/11/24	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
08/11/24	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
08/11/24	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
08/11/24	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/10/24	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

02/01/25	Avinger : Private Placement Form 8 K	PU
08/11/24	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/11/24	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
08/11/24	Avinger: Q3 Earnings Snapshot	AQ
25/10/24	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Avinger, Inc. Stock

Stocks

AVGR

US0537348775

Advanced Medical Equipment & Technology

Valuation: Avinger, Inc.

Latest news: Avinger, Inc.

Analysts' recommendations: Avinger, Inc.

Press Releases: Avinger, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Avinger, Inc.

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Date	Insider	Type	Main position	Quantity	% Market Cap.
1/23/25 A	Himanshu Patel	Sell	Founder	2,215	0.0669%
1/23/25 A	Nabeel Subainati	Sell	Chief Financial Officer	1,255	0.0379%
1/23/25 A	Jeffrey Soinski	Sell	Chief Executive Officer	3,690	0.1115%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER, INC.	-20.74%	-.--%	-.--%	-89.23%	1.52M
THERMO FISHER SCIENTIFIC, INC.	+3.35%	-0.27%	+24.56%	+35.89%	250B
DANAHER CORPORATION	+3.34%	-2.69%	+2.89%	+2.00%	156B
INTUITIVE SURGICAL, INC.	+3.71%	-2.00%	-10.14%	+40.12%	144B
BOSTON SCIENTIFIC CORPORATION	-0.47%	-3.88%	-56.43%	-17.96%	61.45B
EDWARDS LIFESCIENCES CORPORATION	+2.44%	+0.46%	+13.18%	+20.82%	50.28B
SIEMENS HEALTHINEERS AG	-1.08%	-3.15%	-21.39%	-21.55%	46.73B
AGILENT TECHNOLOGIES, INC.	+2.09%	-2.24%	+20.93%	+55.22%	48.29B
VEEVA SYSTEMS INC.	+3.70%	+1.25%	-4.33%	+40.74%	45.89B
WATERS CORPORATION	+3.51%	-0.64%	+34.02%	+65.46%	43.24B
Average	+0.11%	-0.01%	+0.33%	+13.15%	84.52B
Weighted average by Cap.	+2.86%	-2.77%	+4.28%	+25.27%

	2022	2023
Net sales	8.27M 7.38M 6.88M 6.26M 11.78M 797M 11.87M 83.08M 32.32M 407M 31.06M 30.39M 1.31B	7.65M 6.83M 6.36M 5.79M 10.9M 737M 10.98M 76.85M 29.9M 376M 28.73M 28.11M 1.21B
Net income	-17.62M -15.72M -14.65M -13.33M -25.1M -1.7B -25.29M -177M -68.86M -866M -66.16M -64.73M -2.78B	-18.32M -16.34M -15.23M -13.86M -26.09M -1.76B -26.29M -184M -71.58M -900M -68.77M -67.29M -2.89B
Net Debt	1.76M 1.57M 1.46M 1.33M 2.5M 169M 2.52M 17.63M 6.86M 86.31M 6.59M 6.45M 277M	10.12M 9.03M 8.41M 7.65M 14.41M 975M 14.52M 102M 39.54M 497M 37.99M 37.17M 1.6B

3 years	0.36	6.55
5 years	0.36	288.9
10 years	0.36	618,002.47